The simultaneous effectiveness of multiple shelf registrations signals Catalyst is prepared to raise capital at any time. Monitor for a subsequent prospectus supplement or 424B filing that would disclose actual offering size and terms, that event would be the real catalyst for price movement. Until then, the overhang may weigh on the stock given the bearish analyst consensus.
CPRX drugs
CPRX drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK AT ENTRY AT T+5- T+0 · Jul 17 $31.49entry
- T+1 · 4mo ago 0.00%α +0.16% · $31.49
- T+5 · 4mo ago 0.00%α +0.59% · $31.49
- T+20 · due 3mo ago Pending
- T+60 · due 5w ago Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Catalyst Pharmaceuticals received SEC effectiveness on July 16, 2026 for four separate shelf registration statements (File Nos. 333-215315, 333-170945, 333-151368, 333-240052, and 333-219259), each previously filed as POS AM amendments. This batch of EFFECT notices confirms the company can now sell securities under multiple shelf registrations at any time, creating a potential dilution overhang. The simultaneous effectiveness of multiple shelves suggests preparation for flexible capital raising, though no specific offering size or timing is disclosed in these filings.
Key Facts
- Four shelf registration statements (File Nos. 333-215315, 333-170945, 333-151368, 333-240052, 333-219259) were declared effective by the SEC on July 16, 2026.
- Each shelf was preceded by a POS AM (post-effective amendment) filing, indicating updates to previously filed registration statements.
- No offering size, pricing, or specific security type is disclosed in these EFFECT notices.
- The company has a $3.9B market cap and analyst consensus is 0% bullish (6 Hold, 1 Sell, 2 Strong Sell).
- Institutional 13F data shows only $28M in disclosed holdings from top holders, with 2 adds and 1 trim in the most recent quarter.
Financial Impact
Multiple shelf registrations effective, potential dilution overhang, but no specific dollar amount disclosed in these filings.
Risk Factors
- Potential dilutive equity offering at any time under the now-effective shelf registrations
- Bearish analyst consensus with 0% bullish ratings and 3 sell-equivalent ratings
- Low institutional ownership ($28M disclosed) suggests limited support from large funds
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 24 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (CPRX), Batch item 1 | 9999999995-26-002323 |
| Document: 9999999995-26-002323-index.html | 9999999995-26-002322 |
| Document: 9999999995-26-002323.txt | 9999999995-26-002321 |
| EFFECT Filing (CPRX), Batch item 4 | 9999999995-26-002322 |
| Document: 9999999995-26-002322-index.html | 9999999995-26-002322 |
| Document: 9999999995-26-002322.txt | 9999999995-26-002321 |
| EFFECT Filing (CPRX), Batch item 7 | 9999999995-26-002321 |
| Document: 9999999995-26-002321-index.html | 9999999995-26-002324 |
| Document: 9999999995-26-002321.txt | 9999999995-26-002323 |
| EFFECT Filing (CPRX), Batch item 10 | 9999999995-26-002323 |
| Document: 9999999995-26-002323-index.html | 9999999995-26-002323 |
| Document: 9999999995-26-002323.txt | 9999999995-26-002323 |
| EFFECT Filing (CPRX), Batch item 13 | 9999999995-26-002322 |
| Document: 9999999995-26-002322-index.html | 9999999995-26-002323 |
| Document: 9999999995-26-002322.txt | 9999999995-26-002323 |
| EFFECT Filing (CPRX), Batch item 16 | 9999999995-26-002321 |
| Document: 9999999995-26-002321-index.html | 9999999995-26-002323 |
| Document: 9999999995-26-002321.txt | 9999999995-26-002323 |
| EFFECT Filing (CPRX), Batch item 19 | 9999999995-26-002325 |
| Document: 9999999995-26-002325-index.html | 9999999995-26-002323 |
| Document: 9999999995-26-002325.txt | 9999999995-26-002323 |
| EFFECT Filing (CPRX), Batch item 22 | 9999999995-26-002324 |
| Document: 9999999995-26-002324-index.html | 9999999995-26-002323 |
| Document: 9999999995-26-002324.txt | 9999999995-26-002323 |
Track record
16 reports on CPRX
4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +25.72% at T+60 after the Feb 25, 2026 report. 6 of 8 went positive at some point.
Filters
- Nov 4, 202612d ago Institutional Cluster Bearish 4/10 No price data
- Aug 22, 202612w ago Institutional Cluster Mixed 5/10 No price data
- Jul 24, 202616w ago 15-12G Bearish 9/10 Entry $31.49 No price data
- Jul 17, 202617w ago EFFECT Bearish 5/10 Viewing Entry $31.49 No price data
- Jul 15, 202617w ago 25-NSE Bearish 9/10 Entry $31.49 No price data
- Jul 8, 202618w ago 8-K Bullish 6/10 Entry $31.47 No price data
- Jun 30, 202619w ago DEFA14A Neutral 3/10 Entry $31.44 No price data
- Jun 30, 202619w ago 8-K Neutral 4/10 Entry $31.44 No price data
- May 28, 202624w ago PREM14A Bullish 8/10 Entry $31.23 to $31.46 ▲ +0.74% +2.53% vs SPY
- May 12, 202626w ago DEFA14A Neutral 3/10 Entry $31.14 to $31.34 ▲ +0.64% +2.37% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers